Markntel Advisors’ report, Liquid Biopsy Research Report: Trend, Business Growth, Size, Future Scope, Segmentation, Dynamics, and Forecast to 2028, offers a comprehensive guide for the growing industry. The expert team of analysts dedicated significant effort to gathering and evaluating the latest market data, resulting in a detailed and up-to-date report that offers valuable insights for individuals who rely on data-driven decisions, including business owners and analysts. The research report on the Liquid Biopsy presents well-researched facts and figures pertinent to the industry, whether the goal is to explore new markets, launch a new product, or maintain a competitive advantage.
Liquid Biopsy Market Research Report & Market Summary:
The Global Liquid Biopsy Market is projected to grow at a CAGR of around 26% during the forecast period, i.e., 2023-28. The market is significantly driven by the rising cases and prevalence of cancer, along with the increasing awareness and preference for non-invasive treatment procedures. Furthermore, the understanding and appreciation are guided by the several benefits associated with the new liquid biopsy technique, including rapid results, low cost, early prognosis, overcoming tumor heterogeneity, low risk, and non-invasiveness.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/global-liquid-biopsy-market.html
Liquid Biopsy Market Dynamics:
Key Driver-
Surge in Cancer Cases Across the Globe – The number of cancer cases has surged significantly on a global scale. Environmental factors are the leading causes of cancer. The rise in cancer diagnosis has led various countries and international health organizations to undertake various initiatives to spread awareness about cancer. With this increase, Liquid biopsy is preferred for its multiple advantages, counting low-cost, early prognosis, tumor heterogeneity identification, drug resistance, therapeutic drug monitoring, and the most ascendant, patient comfort by eliminating the need for surgery. Consecutively, this increase in preference for Liquid Biopsies is expected to increase the Market during the forecasting period.
Liquid Biopsy Market Segmentation Analysis:
According to MarkNtel study the market is segmented into the following categories:
By Work Process
- Sample Preparation
- Library Preparation
- Sequencing
- Data Analysis
By Technology
- PCR
- RT-PCR
- dPCR
- Multiplex PCR
- Others
- NGS
- FISH
- Other Technologies
By Usage
- RUO
- Clinical
By Sample Type
- Blood
- Urine
- Saliva
- Cerebrospinal Fluid
Here, the Blood sample is estimated to dominate the market in the forecasting years. A blood test is relatively simple, especially for the patient, as it is non-invasive, has no risks, and is painless.
By Products
- Test /Services
- Kits and Consumables
- Instruments
By Circulating Biomarkers
- Circulating Tumor Cells
- Cell-free DNA
- Circulating Cell-Free RNA
- Exosomes and Extracellular Vesicles
- Others
Amongst the above, Circulating Tumor Cells are expected to witness predominant growth during the forecast years. Circulating Tumor Cells (CTCs) are the cells shed by the cancer tumor, which then spread through the bloodstream.
By Disease Type
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Melanoma
- Other Cancers
- Non-Oncology Disorders
By Clinical Application
- Treatment Monitoring
- Prognosis and Recurrence Monitoring
- Treatment Selection
- Diagnosis and Screening
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific.
Of them all, North America is anticipated to attain a significant market share during the forecasting period. It owes principally to the high adoption of advanced technologies like NGS’s presence of well-established pharmaceutical companies, research centers, and biotechnology companies developing tests, funding, and investments from public and private organizations.
As indicated in the latest market research report published by Markntel Advisors, “ Liquid Biopsy Research Report: Forecast (2023-2028)”, this report offers a detailed analysis of the industry, featuring insights into the Liquid Biopsy industry. It encompasses competitor and geographical analyses, as well as recent advancements in the market.
Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/global-liquid-biopsy-market.html
Top Companies Operating in the Liquid Biopsy Market:
- Bio-Rad Laboratories
- Biocept Inc
- Abcodia Ltd
- Chronix Biomedical
- Epic Sciences Inc
- Hoffmann-La Roche AG
- Cynvenio Biosystems, Inc.
- GUARDANT HEALTH, INC
- Illumina, Inc.
- NeoGenomics Laboratories, Inc.
- Menarini Silicon Biosystems, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific
- Personal Genome Diagnostics, Inc.
- Qiagen N.V.
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*
Other Report:
- Asset Drone, ABJ Drones, Terra Drone, Cyberhawk are top Utility Drone companies.
- The UAV Sense-and-Avoid System Market is anticipated to exceed the Market size of USD 4Billion by 2025 says- MarkNtel Advisors.
Key Report Highlights:
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Frequently Asked Questions (FAQs)-
- What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
- What are the trends influencing the current scenario of the market?
- What leading factors would propel and impede the industry across the geography?
- How has the industry been evolving in terms of geography & Liquid Biopsy Market adoption?
- How has the competition been shaping up across the geography?
- Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call + +1 628 895 8081, +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
